Tapewire

Nasdaq · USD

IRTC

iRhythm Holdings, Inc.

Export transactions ↓
Tapewire entity
1499
SEC CIK
0001388658
Parsed reports
491

Last 12 months

Inside the activity.

1 purchase rows · 65 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202507
Dec 202502
Jan 202600
Feb 2026014
Mar 2026023
Apr 202600
May 202616
Jun 202602
Jul 202602
Aug 202608
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 28, 2025 Filed Dec 2, 2025 23:34 UTC
Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH
GrantCommon Stock 250 $74.72 $18,678.75
Disclosure

SEC source: 0001932682-25-000005 · wk-form4_1764718472.xml · nonDerivative · entry 1

Turakhia Minang · CIK 0001932682 · CHIEF MED/SCI OFCR EVP ADVTECH

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,643

F1 · shares: Mr. Turakhia is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period June 1, 2025 through November 30, 2025. This transaction is exempt from Section 16(b) under Rule 16b-3.

Read SEC document
November 28, 2025 Filed Dec 2, 2025 23:22 UTC
Rosenbaum Marc WadeChief Accounting Officer
GrantCommon Stock 2 $119.55 $239.11
Disclosure

SEC source: 0001929535-25-000008 · wk-form4_1764717763.xml · nonDerivative · entry 1

Rosenbaum Marc Wade · CIK 0001929535 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,881

F1 · shares: Mr. Rosenbaum is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period June 1, 2025 through November 30, 2025. This transaction is exempt from Section 16(b) under Rule 16b-3.

Read SEC document
November 10, 2025 Filed Nov 12, 2025 21:33 UTC Exercise / conversionEmployee Stock Option (right to buy) · Derivative 5,312 $10.71 Strike: $10.71 $56,891.52
Disclosure

SEC source: 0001316065-25-000009 · wk-form4_1762983236.xml · derivative · entry 8

TALWALKAR ABHIJIT Y · CIK 0001316065 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,624

Underlying: Common Stock · 5,312 shares

Expires 2026-05-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.expiration_date: The option, originally granted on May 23, 2016 for 21,248 shares, vested in thirty-six equal monthly installments. This option has an expiration date of May 23, 2026. The Rule 10b5-1 trading plan of Mr. Talwalkar solely covers shares subject to options expiring in 2026 and 2027.

Read SEC document
November 10, 2025 Filed Nov 12, 2025 21:33 UTC SaleCommon Stock 89 $177.85 $15,828.65
Disclosure

SEC source: 0001316065-25-000009 · wk-form4_1762983236.xml · nonDerivative · entry 7

TALWALKAR ABHIJIT Y · CIK 0001316065 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,299

F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025.

Read SEC document
November 10, 2025 Filed Nov 12, 2025 21:33 UTC SaleCommon Stock 637 $175.96 $112,084.16
Disclosure

SEC source: 0001316065-25-000009 · wk-form4_1762983236.xml · nonDerivative · entry 6

TALWALKAR ABHIJIT Y · CIK 0001316065 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,388

F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025.

F6 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on November 10, 2025. The actual sale prices ranged from a low of $175.7650 to a high of $176.1150, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points.

Read SEC document
November 10, 2025 Filed Nov 12, 2025 21:33 UTC SaleCommon Stock 1,300 $174.94 $227,427.46
Disclosure

SEC source: 0001316065-25-000009 · wk-form4_1762983236.xml · nonDerivative · entry 5

TALWALKAR ABHIJIT Y · CIK 0001316065 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,025

F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025.

F5 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on November 10, 2025. The actual sale prices ranged from a low of $174.7500 to a high of $175.2800, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points.

Read SEC document
November 10, 2025 Filed Nov 12, 2025 21:33 UTC SaleCommon Stock 1,585 $174.38 $276,395.31
Disclosure

SEC source: 0001316065-25-000009 · wk-form4_1762983236.xml · nonDerivative · entry 4

TALWALKAR ABHIJIT Y · CIK 0001316065 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,325

F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025.

F4 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on November 10, 2025. The actual sale prices ranged from a low of $173.8700 to a high of $174.7000 inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points.

Read SEC document
November 10, 2025 Filed Nov 12, 2025 21:33 UTC SaleCommon Stock 222 $172.83 $38,367.15
Disclosure

SEC source: 0001316065-25-000009 · wk-form4_1762983236.xml · nonDerivative · entry 3

TALWALKAR ABHIJIT Y · CIK 0001316065 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,910

F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025.

F3 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on November 10, 2025. The actual sale prices ranged from a low of $172.7450 to a high of $172.9600, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points.

Read SEC document
November 10, 2025 Filed Nov 12, 2025 21:33 UTC SaleCommon Stock 1,479 $172.32 $254,858.91
Disclosure

SEC source: 0001316065-25-000009 · wk-form4_1762983236.xml · nonDerivative · entry 2

TALWALKAR ABHIJIT Y · CIK 0001316065 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,132

F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025.

F2 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on November 10, 2025. The actual sale prices ranged from a low of $171.7350 to a high of $172.7000, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points.

Read SEC document
November 10, 2025 Filed Nov 12, 2025 21:33 UTC Exercise / conversionCommon Stock 5,312 $10.71 $56,891.52
Disclosure

SEC source: 0001316065-25-000009 · wk-form4_1762983236.xml · nonDerivative · entry 1

TALWALKAR ABHIJIT Y · CIK 0001316065 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,611

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025.

Read SEC document
November 03, 2025 Filed Nov 4, 2025 22:04 UTC
Blackford Quentin S.Director · President and CEO
SaleCommon Stock 14,059 $182.94 $2,571,907.07
Disclosure

SEC source: 0001612451-25-000005 · wk-form4_1762293847.xml · nonDerivative · entry 1

Blackford Quentin S. · CIK 0001612451 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,979

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units.

Read SEC document
October 31, 2025 Filed Nov 3, 2025 16:30 UTC
Wilson Daniel G.Chief Financial Officer
SaleCommon Stock 8,000 $207.44 $1,659,520.00
Disclosure

SEC source: 0001860745-25-000009 · wk-form4_1762205433.xml · nonDerivative · entry 1

Wilson Daniel G. · CIK 0001860745 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,470

F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 14, 2024.

Read SEC document
September 03, 2025 Filed Sep 4, 2025 17:14 UTC
Wilson Daniel G.Chief Financial Officer
SaleCommon Stock 5,000 $175.00 $875,000.00
Disclosure

SEC source: 0001860745-25-000007 · wk-form4_1757020478.xml · nonDerivative · entry 1

Wilson Daniel G. · CIK 0001860745 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,470

F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by Mr. Wilson on November 14, 2024.

Read SEC document
September 02, 2025 Filed Sep 3, 2025 16:30 UTC
Wilson Daniel G.Chief Financial Officer
SaleCommon Stock 737 $167.28 $123,285.36
Disclosure

SEC source: 0001860745-25-000005 · wk-form4_1756931413.xml · nonDerivative · entry 1

Wilson Daniel G. · CIK 0001860745 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,470

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of RSUs.

Read SEC document
August 22, 2025 Filed Aug 22, 2025 22:27 UTC
Shrishrimal SumiEVP, Chief Risk Officer
SaleCommon Stock 653 $167.12 $109,129.36
Disclosure

SEC source: 0001850687-25-000006 · wk-form4_1755901669.xml · nonDerivative · entry 1

Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,032

F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 23, 2025.

Read SEC document
August 11, 2025 Filed Aug 12, 2025 20:38 UTC Exercise / conversionEmployee Stock Option (right to buy) · Derivative 5,312 $0.00 Strike: $10.71 $0.00
Disclosure

SEC source: 0001316065-25-000005 · wk-form4_1755031077.xml · derivative · entry 4

TALWALKAR ABHIJIT Y · CIK 0001316065 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,936

Underlying: Common Stock · 5,312 shares

Expires 2026-05-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.expiration_date: The option, originally granted on May 23, 2016 for 21,248 shares, vested in thirty-six equal monthly installments. This option has an expiration date of May 23, 2026. The Rule 10b5-1 trading plan of Mr. Talwalkar solely covers shares subject to options expiring in 2026 and 2027.

Read SEC document
August 11, 2025 Filed Aug 12, 2025 20:38 UTC SaleCommon Stock 2,129 $158.68 $337,828.02
Disclosure

SEC source: 0001316065-25-000005 · wk-form4_1755031077.xml · nonDerivative · entry 3

TALWALKAR ABHIJIT Y · CIK 0001316065 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,299

F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025.

F3 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 11, 2025. The actual sale prices ranged from a low of $158.3100 to a high of $159.0000, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points.

Read SEC document
August 11, 2025 Filed Aug 12, 2025 20:38 UTC SaleCommon Stock 3,183 $157.57 $501,552.63
Disclosure

SEC source: 0001316065-25-000005 · wk-form4_1755031077.xml · nonDerivative · entry 2

TALWALKAR ABHIJIT Y · CIK 0001316065 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,428

F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025.

F2 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 11, 2025. The actual sale prices ranged from a low of $157.2350 to a high of $158.1800, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points.

Read SEC document
August 11, 2025 Filed Aug 12, 2025 20:38 UTC Exercise / conversionCommon Stock 5,312 $10.71 $56,891.52
Disclosure

SEC source: 0001316065-25-000005 · wk-form4_1755031077.xml · nonDerivative · entry 1

TALWALKAR ABHIJIT Y · CIK 0001316065 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,611

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025.

Read SEC document
August 11, 2025 Filed Aug 12, 2025 20:39 UTC
Rosenbaum Marc WadeChief Accounting Officer
SaleCommon Stock 226 $158.93 $35,918.18
Disclosure

SEC source: 0001929535-25-000006 · wk-form4_1755031145.xml · nonDerivative · entry 1

Rosenbaum Marc Wade · CIK 0001929535 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,879

F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2025.

Read SEC document
August 06, 2025 Filed Aug 7, 2025 20:57 UTC
Patterson ChadChief Commercial Officer
SaleCommon Stock 2,555 $158.97 $406,168.35
Disclosure

SEC source: 0001850152-25-000005 · wk-form4_1754600252.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,667

F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 25, 2024.

Read SEC document
August 05, 2025 Filed Aug 6, 2025 21:10 UTC
Blackford Quentin S.Director · President and CEO
SaleCommon Stock 306 $165.00 $50,490.00
Disclosure

SEC source: 0001388658-25-000204 · wk-form4_1754514621.xml · nonDerivative · entry 7

Blackford Quentin S. · CIK 0001612451 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 179,038

F1 · shares: All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 5, 2025.

Read SEC document
August 05, 2025 Filed Aug 6, 2025 21:10 UTC
Blackford Quentin S.Director · President and CEO
SaleCommon Stock 3,174 $163.93 $520,300.81
Disclosure

SEC source: 0001388658-25-000204 · wk-form4_1754514621.xml · nonDerivative · entry 6

Blackford Quentin S. · CIK 0001612451 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 179,344

F1 · shares: All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 5, 2025.

F7 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 5, 2025. The actual sale prices ranged from a low of $163.50 to a high of $164.23, inclusive. The reporting person undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points.

Read SEC document
August 05, 2025 Filed Aug 6, 2025 21:10 UTC
Blackford Quentin S.Director · President and CEO
SaleCommon Stock 1,514 $163.30 $247,229.99
Disclosure

SEC source: 0001388658-25-000204 · wk-form4_1754514621.xml · nonDerivative · entry 5

Blackford Quentin S. · CIK 0001612451 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 182,518

F1 · shares: All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 5, 2025.

F6 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 5, 2025. The actual sale prices ranged from a low of $162.71 to a high of $163.44, inclusive. The reporting person undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points.

Read SEC document
August 05, 2025 Filed Aug 6, 2025 21:10 UTC
Blackford Quentin S.Director · President and CEO
SaleCommon Stock 1,600 $161.92 $259,076.00
Disclosure

SEC source: 0001388658-25-000204 · wk-form4_1754514621.xml · nonDerivative · entry 4

Blackford Quentin S. · CIK 0001612451 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 184,032

F1 · shares: All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 5, 2025.

F5 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 5, 2025. The actual sale prices ranged from a low of $161.63 to a high of $162.41, inclusive. The reporting person undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points.

Read SEC document
August 05, 2025 Filed Aug 6, 2025 21:10 UTC
Blackford Quentin S.Director · President and CEO
SaleCommon Stock 4,905 $160.73 $788,360.54
Disclosure

SEC source: 0001388658-25-000204 · wk-form4_1754514621.xml · nonDerivative · entry 3

Blackford Quentin S. · CIK 0001612451 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 185,632

F1 · shares: All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 5, 2025.

F4 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 5, 2025. The actual sale prices ranged from a low of $160.49 to a high of $161.45, inclusive. The reporting person undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points.

Read SEC document
August 05, 2025 Filed Aug 6, 2025 21:10 UTC
Blackford Quentin S.Director · President and CEO
SaleCommon Stock 9,775 $160.06 $1,564,576.73
Disclosure

SEC source: 0001388658-25-000204 · wk-form4_1754514621.xml · nonDerivative · entry 2

Blackford Quentin S. · CIK 0001612451 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 190,537

F1 · shares: All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 5, 2025.

F3 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 5, 2025. The actual sale prices ranged from a low of $159.53 to a high of $160.44, inclusive. The reporting person undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points.

Read SEC document
August 05, 2025 Filed Aug 6, 2025 21:10 UTC
Blackford Quentin S.Director · President and CEO
SaleCommon Stock 8,726 $158.85 $1,386,157.39
Disclosure

SEC source: 0001388658-25-000204 · wk-form4_1754514621.xml · nonDerivative · entry 1

Blackford Quentin S. · CIK 0001612451 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 200,312

F1 · shares: All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 5, 2025.

F2 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 5, 2025. The actual sale prices ranged from a low of $158.47 to a high of $159.42, inclusive. The reporting person undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points.

Read SEC document
August 04, 2025 Filed Aug 5, 2025 21:02 UTC
Patterson ChadChief Commercial Officer
SaleCommon Stock 2,707 $164.36 $444,921.71
Disclosure

SEC source: 0001388658-25-000199 · wk-form4_1754427734.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,222

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of RSUs.

Read SEC document
August 04, 2025 Filed Aug 5, 2025 21:03 UTC
Smith MervinEVP Strategic Business Ops
SaleCommon Stock 616 $164.36 $101,245.58
Disclosure

SEC source: 0001388658-25-000200 · wk-form4_1754427800.xml · nonDerivative · entry 1

Smith Mervin · CIK 0001985217 · EVP Strategic Business Ops

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,838

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of RSUs.

Read SEC document
July 07, 2025 Filed Jul 8, 2025 20:22 UTC GrantCommon Stock 2,035 $0.00 $0.00
Disclosure

SEC source: 0001388658-25-000184 · wk-form4_1752006159.xml · nonDerivative · entry 1

OBOYLE KEVIN C · CIK 0001203567 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,035

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 33.33% of the RSUs vest on July 7, 2026 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Read SEC document
July 07, 2025 Filed Jul 8, 2025 16:23 UTC GrantCommon Stock 2,035 $0.00 $0.00
Disclosure

SEC source: 0001388658-25-000185 · wk-form4_1752006189.xml · nonDerivative · entry 1

MCGINNIS KAREN K · CIK 0001188264 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,035

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 33.33% of the RSUs vest on July 7, 2026 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Read SEC document
July 02, 2025 Filed Jul 2, 2025 21:51 UTC
Turakhia MinangEVP, CMO & CSO
SaleCommon Stock 1,420 $145.41 $206,482.20
Disclosure

SEC source: 0001388658-25-000173 · wk-form4_1751493074.xml · nonDerivative · entry 1

Turakhia Minang · CIK 0001932682 · EVP, CMO & CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,393

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units.

Read SEC document
July 01, 2025 Filed Jul 2, 2025 21:51 UTC
Freeman Sean ClintonEVP, Strategy & Corp Devt
GrantCommon Stock 6,761 $0.00 $0.00
Disclosure

SEC source: 0001388658-25-000174 · wk-form4_1751493097.xml · nonDerivative · entry 1

Freeman Sean Clinton · CIK 0002074661 · EVP, Strategy & Corp Devt

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,761

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on July 1, 2026 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Read SEC document
June 23, 2025 Filed Jun 24, 2025 16:16 UTC
Wilson Daniel G.Chief Financial Officer
SaleCommon Stock 3,000 $150.00 $450,000.00
Disclosure

SEC source: 0001388658-25-000164 · wk-form4_1750796192.xml · nonDerivative · entry 1

Wilson Daniel G. · CIK 0001860745 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,307

F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 14, 2024.

Read SEC document
June 23, 2025 Filed Jun 24, 2025 20:15 UTC
Patterson ChadChief Commercial Officer
SaleCommon Stock 936 $150.00 $140,400.00
Disclosure

SEC source: 0001388658-25-000162 · wk-form4_1750796127.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 48,929

F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 25, 2024.

Read SEC document
June 10, 2025 Filed Jun 11, 2025 20:21 UTC
Patterson ChadChief Commercial Officer
SaleCommon Stock 363 $150.00 $54,450.00
Disclosure

SEC source: 0001388658-25-000158 · wk-form4_1749673286.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 49,865

F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 25, 2024.

Read SEC document
June 02, 2025 Filed Jun 3, 2025 20:18 UTC
Shrishrimal SumiEVP, Chief Risk Officer
SaleCommon Stock 1,608 $140.21 $225,457.68
Disclosure

SEC source: 0001388658-25-000156 · wk-form4_1748981875.xml · nonDerivative · entry 2

Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,685

F2 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units.

Read SEC document
June 02, 2025 Filed Jun 3, 2025 20:17 UTC
Rosenbaum Marc WadeChief Accounting Officer
SaleCommon Stock 696 $140.21 $97,586.16
Disclosure

SEC source: 0001388658-25-000155 · wk-form4_1748981843.xml · nonDerivative · entry 2

Rosenbaum Marc W. · CIK 0001929535 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,105

F2 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units.

Read SEC document
May 30, 2025 Filed Jun 3, 2025 20:18 UTC
Shrishrimal SumiEVP, Chief Risk Officer
GrantCommon Stock 176 $71.46 $12,576.96
Disclosure

SEC source: 0001388658-25-000156 · wk-form4_1748981875.xml · nonDerivative · entry 1

Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,293

F1 · shares: Ms. Shrishrimal is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2024 through May 31, 2025. This transaction is exempt from Section 16(b) under Rule 16b-3.

Read SEC document
May 30, 2025 Filed Jun 3, 2025 20:16 UTC
Patterson ChadChief Commercial Officer
GrantCommon Stock 298 $71.46 $21,295.08
Disclosure

SEC source: 0001388658-25-000154 · wk-form4_1748981789.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,228

F1 · shares: Mr. Patterson is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2024 through May 31, 2025. This transaction is exempt from Section 16(b) under Rule 16b-3.

Read SEC document
May 30, 2025 Filed Jun 3, 2025 20:16 UTC
Blackford Quentin S.Director · President and CEO
GrantCommon Stock 297 $71.46 $21,223.62
Disclosure

SEC source: 0001388658-25-000153 · wk-form4_1748981758.xml · nonDerivative · entry 1

Blackford Quentin S. · CIK 0001612451 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 209,038

F1 · shares: Mr. Blackford is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2024 through May 31, 2025. This transaction is exempt from Section 16(b) under Rule 16b-3.

Read SEC document
May 30, 2025 Filed Jun 3, 2025 20:17 UTC
Rosenbaum Marc WadeChief Accounting Officer
GrantCommon Stock 294 $71.46 $21,009.24
Disclosure

SEC source: 0001388658-25-000155 · wk-form4_1748981843.xml · nonDerivative · entry 1

Rosenbaum Marc W. · CIK 0001929535 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,801

F1 · shares: Mr. Rosenbaum is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2024 through May 31, 2025. This transaction is exempt from Section 16(b) under Rule 16b-3.

Read SEC document
May 30, 2025 Filed Jun 3, 2025 20:15 UTC
Turakhia MinangEVP, CMO & CSO
GrantCommon Stock 318 $74.72 $23,760.96
Disclosure

SEC source: 0001388658-25-000152 · wk-form4_1748981735.xml · nonDerivative · entry 1

Turakhia Minang · CIK 0001932682 · EVP, CMO & CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,813

F1 · shares: Mr. Turakhia is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2024 through May 31, 2025. This transaction is exempt from Section 16(b) under Rule 16b-3.

Read SEC document
May 28, 2025 Filed May 29, 2025 16:04 UTC GrantCommon Stock 1,358 $0.00 $0.00
Disclosure

SEC source: 0001388658-25-000134 · wk-form4_1748549087.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,288

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting.

Read SEC document
May 28, 2025 Filed May 29, 2025 16:01 UTC GrantCommon Stock 1,358 $0.00 $0.00
Disclosure

SEC source: 0001388658-25-000127 · wk-form4_1748548910.xml · nonDerivative · entry 1

RUBASH MARK J · CIK 0001209186 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,788

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting.

Read SEC document
May 28, 2025 Filed May 29, 2025 20:03 UTC GrantCommon Stock 1,358 $0.00 $0.00
Disclosure

SEC source: 0001388658-25-000131 · wk-form4_1748549004.xml · nonDerivative · entry 1

TALWALKAR ABHIJIT Y · CIK 0001316065 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,299

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting.

Read SEC document
May 28, 2025 Filed May 29, 2025 20:06 UTC
YOOR BRIAN BDirector
GrantCommon Stock 1,358 $0.00 $0.00
Disclosure

SEC source: 0001388658-25-000138 · wk-form4_1748549182.xml · nonDerivative · entry 1

YOOR BRIAN B · CIK 0001643528 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,598

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting.

Read SEC document
May 28, 2025 Filed May 29, 2025 20:05 UTC GrantCommon Stock 1,358 $0.00 $0.00
Disclosure

SEC source: 0001388658-25-000136 · wk-form4_1748549132.xml · nonDerivative · entry 1

Bodaken Bruce G. · CIK 0001527009 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,638

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting.

Read SEC document
May 28, 2025 Filed May 29, 2025 20:04 UTC GrantCommon Stock 1,358 $0.00 $0.00
Disclosure

SEC source: 0001388658-25-000132 · wk-form4_1748549040.xml · nonDerivative · entry 1

Bairey Merz Cathleen Noel · CIK 0001738783 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,973

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.